Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-30

FDA Approved: CYANOCOBALAMIN — Original Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' cyanocobalamin as an original generic application, enabling production of a generic vitamin B12 supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYANOCOBALAMIN (cyanocobalamin)

Snippet

ORIG AP for CYANOCOBALAMIN (CYANOCOBALAMIN)